Archive for 'Tag Archives: 'Gosselies''
At the recently held conference hosted by OncoDNA in the IPG building (Gosselies, Belgium) Jean-Pol Detiffe (CEO, OncoDNA) and Martine Piccart (Co-founder and chair, BIG) announced the launch of a multi-year analysis program AURORA, conducted by [...]
OncoDNA: Selected to be NBCC’s (Riyadh, Saudia Arabia) preferred supplier of clinical grade molecular diagnostics for cancer
OncoDNA SA expands its territory with the recent announcement of a supplier agreement with NBCC (National Blood and Cancer Center); a specialized centre for diagnosing and treating blood diseases and cancers located in Riyadh, Saudi Arabia, [...]
As the foundation for the new Walloon Cell Therapy Platform* begins to set in Gosselies, Belgium an exciting new development for Wallonia gets underway. The platform, unique in this sector, will provide Wallonia with a new [...]
OncoDNA of Belgium provides first partnership in Molecular Diagnostics outside of the US for CollabRx, Inc
Belgium based OncoDNA SA, a company providing DNA next generation sequencing (NGS) tests for clinical use in cancer, recently announced a multi-year agreement to purchase CollabRx‘s SaaS-based technology and content resources. The US–based data analytics company, [...]
DNAVision(Gosselies, Belgium) among the first in Europe to receive the ISO 17025 accreditation of exome sequencing service for clinical applications.
An external audit carried out by the Belgian Authorities recently validated DNAVision’s (Gosselies, Belgium) technical competence to carry out exome sequencing* and the ability to consistently produce valid and traceable results. This important validation will allow [...]
Euroscreen has recently announced the completion of a €10 million Series A preferred stock financing led by Vesalius Biocapital II Partners and SRIW(Société Régionale d’Investissement de Wallonie SA). The proceeds of the round will mainly be used to fund and develop the [...]
Launch of OncoDNA(Gosselies, Belgium) to focus entirely on personalized DNA sequencing of cancer patients.
The company will focus entirely on personalized DNA sequencing* of cancer patients. Detiffe, a former CEO and founder of DNAVision, recently announced the launch of OncoDNA(Gosselies, Belgium) after receiving funding of more than €2 million ($2.6 [...]
Bone Therapeutics gets approval for pivotal phase III osteonecrosis trial in Europe and treats first patients with their Advanced Therapy Medicinal Product PREOB®
After receiving clearance from the competent authorities in Europe for its phase III pivotal osteonecrosis* trial with their second generation Advanced Therapy Medicinal Product (ATMP), PREOB®, bone regenerative medicine company Bone Therapeutics recently announced that their [...]
Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics
Euroscreen, a spin-off of ULB with plans of establishing a treatment for endometriosis*, is putting its “services business unit” up for sale. Recognizing the need for capital increases like the other active companies in the biotechnologies [...]